SurVaxM Brain Cancer Vaccine

A new clinical research study at Roswell Park, developed by Robert Fenstermaker, MD, and Michael Ciesielski, PhD, will test a first-of-its-kind cancer “vaccine” that may prove effective against many forms of solid-tumor cancers.